scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00280-013-2319-2 |
P698 | PubMed publication ID | 24158402 |
P2093 | author name string | Hua Song | |
Xue-ying Chen | |||
Bin-hua Pan | |||
Jun-qing Mao | |||
Ling-yan Zhang | |||
Wei-qun Xu | |||
Yong-min Tang | |||
Jing-yuang Li | |||
P2860 | cites work | Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data | Q33399245 |
Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer | Q34780653 | ||
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments | Q37034349 | ||
Recent research advances in childhood acute lymphoblastic leukemia | Q37815272 | ||
Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country | Q37978262 | ||
Long-term outcome of childhood acute lymphoblastic leukemia treated in China | Q39847866 | ||
Influence of high‐dose methotrexate therapy (HD‐MTX) on glomerular and tubular kidney function | Q44401633 | ||
High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance | Q44916270 | ||
Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China | Q46961911 | ||
Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis | Q57618557 | ||
P433 | issue | 1 | |
P921 | main subject | methotrexate | Q422232 |
P304 | page(s) | 79-86 | |
P577 | publication date | 2013-10-25 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies. | |
P478 | volume | 73 |
Q88626086 | Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate |
Q37088471 | New approaches in primary central nervous system lymphoma |
Q37496637 | Preventing and Managing Toxicities of High-Dose Methotrexate |
Q39185721 | Primary central nervous system lymphoma: essential points in diagnosis and management |
Q47772751 | Purification and activity characterization of polysaccharides in the medicinal lichen Umbilicaria tornata from Taibai Mountain, China |
Q33427484 | Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate |
Q89782225 | Severe Oral Mucositis in Pediatric Cancer Patients: Survival Analysis and Predictive Factors |
Q30397448 | What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? |
Search more.